You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.
The researchers said this new data could lead to the development of effective therapies for patients with hereditary leiomyomatosis and renal cell carcinoma.
In PNAS this week: variants in Bloom syndrome-related gene increase mesothelioma risk, Streptococcus host transcriptome atlas, and more.
The consortium aims to harmonize the use of homologous recombination deficiency as a biomarker to guide certain treatment types in cancer patients.
NCI researchers performed a multi-platform study to elucidate the factors that can contribute to a patient's better-than-expected response to a drug.
In PNAS this week: genetic diversity and more among Nipah viruses, glycome expression study of the brain, and more.
In PLOS this week: analysis of link between somatic copy number and telomere length, sequencing study of individuals with gallbladder S. Typhi colonization, and more.
The first stage generated a range of tools and resources for studying the nucleus in time and space including publicly available datasets and software.
The findings demonstrate the value of multi-cohort platform trials as an option for refractory cancer patients with particularly rare genomic tumor alterations.
In PNAS this week: characterization of diarrhea-causing swine coronavirus, metabolic differences in models with TP53 variant, and more.
The University of Michigan spinout will use the funds to develop its InheRET platform, increase integration with EHRs, as well as increase its workforce and userbase.
The Wall Street Journal reports on gaps in COVID-19 testing affecting less affluent urban areas and rural locations.
According to NBC News, new SARS-CoV-2 variants are making it harder for researchers to model the course of the pandemic.
The New York Times reports that experts say President Joe Biden's goal of vaccinating 1 million people a day in the US in the next 100 days is too low a bar.
In Science this week: single-cell lineage tracing technique applied to study lung cancer metastasis, and more.